Free Trial

Venator Management LLC Increases Holdings in Oscar Health, Inc. $OSCR

Oscar Health logo with Finance background

Key Points

  • Venator Management LLC increased its holdings in Oscar Health, Inc. by 25%, owning a total of 125,000 shares after purchasing an additional 25,000 shares in the 1st quarter.
  • Large investors like Southeastern Asset Management and Jacobs Levy Equity Management also increased their positions, with 75.70% of the stock now owned by institutional investors.
  • Oscar Health's stock has received multiple downgrades, with UBS Group lowering its price target from $15.00 to $11.00, contributing to an overall rating of "Strong Sell."
  • Looking to export and analyze Oscar Health data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Venator Management LLC grew its holdings in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 25.0% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 125,000 shares of the company's stock after purchasing an additional 25,000 shares during the quarter. Oscar Health makes up 0.5% of Venator Management LLC's investment portfolio, making the stock its 18th largest holding. Venator Management LLC's holdings in Oscar Health were worth $1,639,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Southeastern Asset Management Inc. TN increased its position in shares of Oscar Health by 52.2% during the 4th quarter. Southeastern Asset Management Inc. TN now owns 3,131,084 shares of the company's stock valued at $42,082,000 after purchasing an additional 1,073,359 shares during the last quarter. Jacobs Levy Equity Management Inc. increased its holdings in Oscar Health by 37.8% in the 4th quarter. Jacobs Levy Equity Management Inc. now owns 1,741,306 shares of the company's stock worth $23,403,000 after acquiring an additional 477,634 shares during the last quarter. Man Group plc increased its holdings in Oscar Health by 344.8% in the 4th quarter. Man Group plc now owns 1,813,216 shares of the company's stock worth $24,370,000 after acquiring an additional 1,405,554 shares during the last quarter. Victory Capital Management Inc. increased its holdings in Oscar Health by 23.8% in the 1st quarter. Victory Capital Management Inc. now owns 285,997 shares of the company's stock worth $3,749,000 after acquiring an additional 54,938 shares during the last quarter. Finally, Toronto Dominion Bank purchased a new stake in Oscar Health in the 4th quarter worth about $1,008,000. 75.70% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on OSCR. UBS Group reissued a "sell" rating and issued a $11.00 price objective (down previously from $15.00) on shares of Oscar Health in a report on Tuesday, July 15th. Baird R W lowered Oscar Health from a "strong-buy" rating to a "hold" rating in a report on Friday, July 25th. Piper Sandler decreased their price objective on Oscar Health from $14.00 to $13.00 and set a "neutral" rating for the company in a report on Thursday, August 14th. Robert W. Baird reissued a "neutral" rating and issued a $14.00 price objective (down previously from $28.00) on shares of Oscar Health in a report on Friday, July 25th. Finally, Wells Fargo & Company lowered Oscar Health from an "equal weight" rating to an "underweight" rating and decreased their price objective for the stock from $16.00 to $10.00 in a report on Friday, July 11th. Four investment analysts have rated the stock with a Hold rating and five have issued a Sell rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Strong Sell" and an average target price of $12.07.

Check Out Our Latest Analysis on OSCR

Oscar Health Stock Performance

Shares of NYSE OSCR opened at $15.2370 on Thursday. The stock's 50-day moving average is $16.04 and its 200 day moving average is $14.80. The stock has a market cap of $3.94 billion, a price-to-earnings ratio of -18.81 and a beta of 1.86. Oscar Health, Inc. has a 1-year low of $11.20 and a 1-year high of $23.79. The company has a current ratio of 0.86, a quick ratio of 0.86 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR - Get Free Report) last released its earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share for the quarter, topping analysts' consensus estimates of ($0.90) by $0.01. The company had revenue of $2.86 billion during the quarter, compared to the consensus estimate of $2.88 billion. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%.Oscar Health's quarterly revenue was up 29.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.20 EPS. On average, sell-side analysts anticipate that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Oscar Health Company Profile

(Free Report)

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

See Also

Want to see what other hedge funds are holding OSCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR - Free Report).

Institutional Ownership by Quarter for Oscar Health (NYSE:OSCR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Oscar Health Right Now?

Before you consider Oscar Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.

While Oscar Health currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines